Tag - obesity

Markets

BTIG cuts Obalon Therapeutics PT to $7 from $13

BTIG lowered its price target for Obalon Therapeutics (NASDAQ:OBLN) to $7 from $13 after the company reported in-line fourth quarter results and guidance for 2018. The stock finished at $4.01 on March 5. Obalon is...

March 6, 2018

Feature

M Pharma advancing technologies for obesity and diabetes

By Len Zehr M Pharmaceutical (OTCQB:MPHMF; CSE:MQ; FWB:T3F1.F) is advancing a family of biomedical technologies to manage obesity – TriMeo and TriMtec – and eMosquito to manage diabetes. “All three of our technologies...

July 7, 2015

Feature

In conversation with Kelly Close

By Len Zehr As president and founder of Close Concerns, a healthcare information firm focused on diabetes and obesity, Kelly Close says her passion comes from her extensive professional work as well as her personal...

September 24, 2013

Tag - obesity

BTIG cuts Obalon Therapeutics PT to $7 from $13

M Pharma advancing technologies for obesity and diabetes

In conversation with Kelly Close

General

More